1. Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway
   Zhanchi Xu et al, 2022, Frontiers in Pharmacology CrossRef
2. Astragalus Mongholicus: A review of its anti-fibrosis properties
   Fengying Gong et al, 2022, Frontiers in Pharmacology CrossRef
3. Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
   Lvzhuo Zhang et al, 2024, Phytotherapy Research CrossRef
4. Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism
   Hui-zhong Xue et al, 2024, Journal of Diabetes Research CrossRef
5. Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy
   Ying-Ying Li et al, 2022, Frontiers in Pharmacology CrossRef
6. The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
   Lin Li et al, 2023, Drug Design, Development and Therapy CrossRef
7. Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
   Xiao-Yuan Liu et al, 2022, Frontiers in Pharmacology CrossRef
8. Natural products: potential drugs for the treatment of renal fibrosis
   Zijun Zhou et al, 2022, Chinese Medicine CrossRef
9. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease
   Mingming Zhao et al, 2021, Frontiers in Pharmacology CrossRef